Brief: Relay Therapeutics Q3 Net Income USD -74.149 Million Vs. IBES Estimate USD -73.9 Million
06/11/2025 21:05
Nov 06 (Reuters) - Relay Therapeutics Q3 operating expenses USD 80.391 million. Q3 operating income USD -80.391 million Q3 basic EPS USD -0.43 Q3 EPS USD -0.43
Recent news on Relay Therapeutics
See all newsBrief: X-Chem Announces Phase 3 Milestone In Collaboration With Relay Therapeutics
Relay Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Relay Therapeutics Q2 revenue misses estimates on higher R&D expenses; net loss widens
Brief: Relay Therapeutics Q2 Net Income USD -83.707 Million Vs. IBES Estimate USD -74.2 Million
U.S. RESEARCH ROUNDUP- Alliant Energy, Prog Holdings, Travelers